The Valley Desk

ArticleInflammatory bowel diseasesPublished

Real-world Evidence Comparing Tofacitinib and Vedolizumab in Anti-TNF-experienced Patients With Ulcerative Colitis

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Inflammatory bowel diseases
Published
Subject terms
Humans; Colitis, Ulcerative; Piperidines; Pyrimidines; Treatment Outcome; Cohort Studies; Antibodies, Monoclonal, Humanized; Tumor Necrosis Factor Inhibitors; Ulcerative colitis; Comparative Effectiveness; Vedolizumab; Tofacitinib
PubMed ID
37358904
Added to directory
Source checked

Report a correction or request removal